HIPAA Alert: Potential Data Breach Learn More

Search
Close this search box.
Portrait of Dr. Chitra Kumar

Chitra Kumar, MD

Board Certifications: Internal Medicine and Medical Oncology

Languages: English, Hindi and Medical Spanish

Locations: Edison, NJ

Call Edison, NJ: (908) 755-1165

Chitra Kumar, MD, is a medical oncologist with the Regional Cancer Care Associates (RCCA) network. She serves patients at RCCA’s Edison, NJ, location with cutting-edge treatments for a variety of cancer types and hematology conditions. She has worked in medical oncology for over 30 years, giving her extensive experience in cancer care, and follows an approach rooted in compassion and individualized treatment. Patients can make an appointment with Dr. Kumar by contacting RCCA today.

Dr. Kumar has over 30 years of experience in treating cancer. Like many RCCA oncologists, she does not specialize in any single cancer type or treatment. Her expertise covers a wide range of solid tumor malignancies, including:

She also treats patients with anemia. Her treatment philosophy is centered on compassion. Dr. Kumar believes every patient is unique and requires an individualized approach. She creates a supportive environment where patients can discuss their experiences, values, and goals when making care decisions. She also prioritizes communication, making sure patients understand their diagnosis and treatment options. This emphasis helps her collaborate with patients to develop a care plan aligned to their needs.

Academic Appointments and Achievements

Before joining the RCCA team, Dr. Kumar served as the president of the Hudson County Medical Society. In this capacity, she organized hundreds of physicians and healthcare workers to promote community health. She also wrote numerous educational articles on multiple topics, including cancer screening. These articles were published in community journals to increase patient awareness.

Dr. Kumar is also a member of multiple national and international medical organizations, including:

These memberships put her in contact with thousands of other oncologists, researchers, and medical professionals, who work together to improve the standards of care around the world.

Education

Medical school: Rajendra Medical College, 1976

Internship: Jersey City Medical Center, Internal Medicine, 1981

Residency: Jersey City Medical Center, Internal Medicine, 1981; St. John’s Episcopal Hospital, Internal Medicine, 1982

Fellowship: Maimonides Medical Center, Hematology and Oncology, 1984

Board certifications: Internal Medicine and Medical Oncology

About Chitra Kumar, MD

After over 30 years of treating patients for cancer, Dr. Kumar has come to understand the importance of trust. She encourages open communication between patients, family members, and the healthcare team to foster an environment where everybody feels heard and supported. “While a cancer diagnosis can be overwhelming,” she says, “it’s crucial to remember that you are not alone. Together, we can navigate this journey.”

The first factor in building trust is acknowledgement of the individual. Dr. Kumar believes that each patient is unique, bringing their own story, fears, and dreams into their treatment. Her role is to educate patients while ensuring that their voice is heard in return. This fosters a collaborative approach to planning where the patient and physician work together to develop a personalized plan.

Dr. Kumar also facilitates trust by focusing on the patient’s well-being. Her treatment approach does not aim solely to eliminate disease; she also strives to improve the patient’s comfort at every stage of the care process. “I look to find moments of joy amidst the challenges,” she explains, “and to celebrate small victories” to foster hope and enhance the patient’s quality of life.

Those moments of hope are what keep Dr. Kumar motivated in her practice. To her, the most rewarding aspect of practicing oncology is the opportunity to watch patients regain their strength and joy for living. “Those moments – when they share their hopes for the future and express gratitude for the care they’ve received – remind me of the profound impact we can have,” says Dr. Kumar. “These smiles symbolize not just an improvement in their condition, but also a renewed sense of hope.”

Patients’ smiles also teach her the importance of perspective. “Many patients demonstrate incredible strength in the face of adversity,” she says. “Hope can thrive even in the toughest circumstances.”

Hope is also becoming easier. Now is an exciting time to practice medical oncology. Dr. Kumar sees new advances daily. Chemotherapy regimens are becoming more effective with fewer side effects, while immunotherapy offers a revolutionary approach that harnesses the body’s own immune system. Targeted therapies, meanwhile, focus on specific molecular alterations to precisely attack and eliminate cancer cells while minimizing damage to healthy tissue. These developments have all led to improved responses for patients, including positive outcomes for cancers that were previously hard to treat.

“Moreover,” she adds, “an increasing emphasis on quality of life is shaping our treatment strategies.” Oncologists now place greater priority on the patient’s ability to enjoy a meaningful life with easier treatments and more comprehensive support services. “This holistic approach, combined with ongoing research and clinical trials, fosters hope and opens new possibilities,” concludes Dr. Kumar. “Every day brings the potential for breakthroughs that can change lives.”

Locations

Dr. Kumar serves patients at RCCA in Edison, NJ

15 Main Street Suite 1
Edison, NJ, 08837

Hospital Affiliations

She also maintains multiple affiliations with local treatment centers, including:

We are here for you

For more information or to schedule an appointment, call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.

Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.